() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: USPTO

Pivot Naturals LLC Receives Three Additional Notices of Allowance from USPTO

Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that its wholly-owned subsidiary, Pivot Naturals LLC, has received three more Notices of Allowance from the U.S. Patent and Trademark Office ("USPTO") for patent applications related to its RTIC "Ready-To-Infuse Cannabis" powderization technology
Read more

Neptune Files Two Patent Applications for Innovative Cannabis Extraction Processes

The extraction processes provide highly-efficient methods to obtain cannabinoids and other desired compounds from the cannabis plant at a greater purity than conventional methods. Both processes are applicable to marijuana and hemp and will be incorporated into the company's Good Manufacturing Practices (GMP)-certified extraction facility in Sherbrooke, QC upon approval of the applicable licensing to produce cannabis extract (pursuant to the Access to Cannabis for Medical Purposes Regulations).  As a late-stage applicant, Neptune is currently working with Health Canada authorities to complete the licensing process.
Read more